NCT05520892

Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children

A Multicenter, Randomized Controlled Study of Two Regimens of Intravenous Immune Globulin in the Treatment of Newly Diagnosed Immune Thrombocytopenia in Children

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 580 (estimated)
• Sponsor: Fujian Medical University Union Hospital · Academic / Other
• Sex: All
• Age: 29 Days – 14 Years
• Healthy volunteers: Not accepted

Summary

To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia, and to reduce related adverse reactions and economic burdens on the premise of ensuring the remission rate

Conditions

• Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment

Interventions

Type	Name	Description
DRUG	intravenous immunoglobulin	To compare the efficacy of two different dosage regimens of intravenous immune globulin (IVIG) in the treatment of children with newly diagnosed immune thrombocytopenia

Timeline

• Start date: 2022-10-06
• Primary completion: 2025-08-31
• Completion: 2026-08-31
• First posted: 2022-08-30
• Last updated: 2024-05-16

Locations

1 site across 1 country: China